Chemomab Therapeutics Ltd Adr (CMMB)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Chemomab Therapeutics Ltd Adr-Aktie (CMMB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-03-31
Periodenlänge	3 Monate
Operating Expenses
Income/Loss From Continuing Operations Before Tax
Income Tax Expense/Benefit
Income/Loss From Continuing Operations After Tax
Net Income/Loss
Preferred Stock Dividends And Other Adjustments
Attributable To Noncontrolling Interest
Basic Average Shares
Diluted Average Shares
Basic Earnings Per Share
Diluted Earnings Per Share
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic

RPRX

$37.30

0.64%

GMAB

$28.71

0.35%

INCY

$101.57

8.65%

BNTX

$103.95

0.04%

ONC

$311.86

0.44%

INSM

$186.23

1.78%